BACKGROUND: Animal studies indicate that omega-6 fatty acids promote and omega-3 fatty acids inhibit tumor development. This pilot study was designed to evaluate whether these fatty acids are associated with human prostate cancer. METHODS: Levels of erythrocyte membrane omega-3 and omega-6 fatty acids were determined for 67 incident prostate cancer cases and 156 population-based controls. RESULTS: Prostate cancer risk was increased in the highest compared to the lowest quartile of alpha-linolenic acid (OR = 2.6, 95% CI = 1.1-5.8, trend P = 0.01). Positive associations were also observed with higher levels of linoleic acid (OR = 2.1, 95% CI = 0.9-4.8) and total omega-6 fatty acids (OR = 2.3, 95% CI = 1.0-5.4). CONCLUSIONS: Results are consistent with other studies showing that linoleic and total omega-6 fatty acids increase risk of prostate cancer. Contrary to animal studies, alpha-linolenic acid was also positively associated with risk. Further research will be required to clarify the role of these fatty acids in human prostate cancer. Copyright 2001 Wiley-Liss, Inc.
BACKGROUND: Animal studies indicate that omega-6 fatty acids promote and omega-3 fatty acids inhibit tumor development. This pilot study was designed to evaluate whether these fatty acids are associated with human prostate cancer. METHODS: Levels of erythrocyte membrane omega-3 and omega-6 fatty acids were determined for 67 incident prostate cancer cases and 156 population-based controls. RESULTS:Prostate cancer risk was increased in the highest compared to the lowest quartile of alpha-linolenic acid (OR = 2.6, 95% CI = 1.1-5.8, trend P = 0.01). Positive associations were also observed with higher levels of linoleic acid (OR = 2.1, 95% CI = 0.9-4.8) and total omega-6 fatty acids (OR = 2.3, 95% CI = 1.0-5.4). CONCLUSIONS: Results are consistent with other studies showing that linoleic and total omega-6 fatty acids increase risk of prostate cancer. Contrary to animal studies, alpha-linolenic acid was also positively associated with risk. Further research will be required to clarify the role of these fatty acids in human prostate cancer. Copyright 2001 Wiley-Liss, Inc.
Authors: Kie Kasuga; Rong Yang; Timothy F Porter; Nitin Agrawal; Nicos A Petasis; Daniel Irimia; Mehmet Toner; Charles N Serhan Journal: J Immunol Date: 2008-12-15 Impact factor: 5.422
Authors: Meng Yang; Azalea Ayuningtyas; Stacey A Kenfield; Howard D Sesso; Hannia Campos; Jing Ma; Meir J Stampfer; Jorge E Chavarro Journal: Cancer Causes Control Date: 2016-08-03 Impact factor: 2.506
Authors: Colleen Pelser; Alison M Mondul; Albert R Hollenbeck; Yikyung Park Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-04 Impact factor: 4.254
Authors: Song-Yi Park; Lynne R Wilkens; Susanne M Henning; Loïc Le Marchand; Kun Gao; Marc T Goodman; Suzanne P Murphy; Brian E Henderson; Laurence N Kolonel Journal: Cancer Causes Control Date: 2008-09-27 Impact factor: 2.506